TP53 alterations correlate with response to VEGF/VEGFR inhibitors: Implications for targeted therapeutics
- Jennifer J. Wheler
- , Filip Janku
- , Aung Naing
- , Yali Li
- , Bettzy Stephen
- , Ralph Zinner
- , Vivek Subbiah
- , Siqing Fu
- , Daniel Karp
- , Gerald S. Falchook
- , Apostolia M. Tsimberidou
- , Sarina Piha-Paul
- , Roosevelt Anderson
- , Danxia Ke
- , Vincent Miller
- , Roman Yelensky
- , J. Jack Lee
- , David Hong
- , Razelle Kurzrock
Producción científica: Article › revisión exhaustiva
107
Citas
(Scopus)